Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione

EU orphan designation number: EU/3/15/1559   
Active ingredient: 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione
Indication: Treatment of systemic sclerosis
Sponsor: Genkyotex S.A.
Forum 2, 218 Avenue Marie Curie, Archamps Technopole, 74166 Saint-Julien-en-Genevois Cedex, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/10/2015 Orphan designation EMA/OD/105/15 (2015)7030 of 9/10/2015
13/02/2018 Transfer of orphan designation EMA/OD/105/15/T/01 (2018)944 of 9/02/2018